Fredun [FREDUN] vs Sun Pharmaceutical [SUNPHARMA] Detailed Stock Comparison
Fredun
BSE
Loading...
Sun Pharmaceutical
NSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Fredun wins in 8 metrics, Sun Pharmaceutical wins in 12 metrics, with 0 ties. Sun Pharmaceutical appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Fredun | Sun Pharmaceutical | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 21.05 | 37.88 | Fredun |
| Price-to-Book Ratio | 3.30 | 5.45 | Fredun |
| Debt-to-Equity Ratio | 118.22 | 3.26 | Sun Pharmaceutical |
| PEG Ratio | 0.63 | -1.94 | Sun Pharmaceutical |
| EV/EBITDA | 10.78 | 24.14 | Fredun |
| Profit Margin (TTM) | 4.50% | 19.29% | Sun Pharmaceutical |
| Operating Margin (TTM) | 12.99% | 24.34% | Sun Pharmaceutical |
| EBITDA Margin (TTM) | 12.99% | 24.34% | Sun Pharmaceutical |
| Return on Equity | 13.96% | 15.08% | Sun Pharmaceutical |
| Return on Assets (TTM) | 4.05% | 11.87% | Sun Pharmaceutical |
| Free Cash Flow (TTM) | $-351.69M | $119.44B | Sun Pharmaceutical |
| Dividend Yield | 0.09% | 1.26% | Sun Pharmaceutical |
| 1-Year Return | 30.92% | -5.82% | Fredun |
| Price-to-Sales Ratio (TTM) | 1.01 | 7.32 | Fredun |
| Enterprise Value | $6.61B | $3,703.34B | Sun Pharmaceutical |
| EV/Revenue Ratio | 1.33 | 6.89 | Fredun |
| Gross Profit Margin (TTM) | 26.25% | 79.58% | Sun Pharmaceutical |
| Revenue per Share (TTM) | $1,128 | $224 | Fredun |
| Earnings per Share (Diluted) | $50.32 | $43.33 | Fredun |
| Beta (Stock Volatility) | 0.84 | 0.31 | Sun Pharmaceutical |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Fredun vs Sun Pharmaceutical Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Fredun | 0.82% | -2.86% | 16.92% | 52.88% | 50.84% | 42.65% |
| Sun Pharmaceutical | -0.53% | 2.69% | -2.45% | -3.91% | -3.48% | -13.15% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Fredun | 30.92% | 8.95% | 351.36% | 8,277.20% | 8,277.20% | 8,277.20% |
| Sun Pharmaceutical | -5.82% | 82.10% | 208.33% | 75.01% | 815.76% | 2,735.38% |
Performance & Financial Health Analysis: Fredun vs Sun Pharmaceutical
| Metric | FREDUN | SUNPHARMA |
|---|---|---|
| Market Information | ||
| Market Cap | ₹5.00B | ₹3.94T |
| Market Cap Category | Small cap | Large cap |
| 10 Day Avg. Volume | 26,613 | 2,563,431 |
| 90 Day Avg. Volume | 21,414 | 2,041,608 |
| Last Close | ₹1,055.75 | ₹1,632.70 |
| 52 Week Range | ₹635.00 - ₹1,143.00 | ₹1,553.05 - ₹1,960.35 |
| % from 52W High | -7.63% | -16.71% |
| All-Time High | ₹1,428.00 (Dec 05, 2022) | ₹1,960.35 (Sep 30, 2024) |
| % from All-Time High | -26.07% | -16.71% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.52% | 0.10% |
| Quarterly Earnings Growth | 0.64% | -0.20% |
| Financial Health | ||
| Profit Margin (TTM) | 0.05% | 0.19% |
| Operating Margin (TTM) | 0.13% | 0.24% |
| Return on Equity (TTM) | 0.14% | 0.15% |
| Debt to Equity (MRQ) | 118.22 | 3.26 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | ₹321.10 | ₹300.99 |
| Cash per Share (MRQ) | ₹12.65 | ₹108.88 |
| Operating Cash Flow (TTM) | ₹-1,140,997,000 | ₹110.84B |
| Levered Free Cash Flow (TTM) | ₹197.39M | ₹109.29B |
| Dividends | ||
| Last 12-Month Dividend Yield | 0.09% | 1.26% |
| Last 12-Month Dividend | ₹0.70 | ₹21.00 |
Valuation & Enterprise Metrics Analysis: Fredun vs Sun Pharmaceutical
| Metric | FREDUN | SUNPHARMA |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 21.05 | 37.88 |
| Forward P/E | N/A | 50.23 |
| PEG Ratio | 0.63 | -1.94 |
| Price to Sales (TTM) | 1.01 | 7.32 |
| Price to Book (MRQ) | 3.30 | 5.45 |
| Market Capitalization | ||
| Market Capitalization | ₹5.00B | ₹3.94T |
| Enterprise Value | ₹6.61B | ₹3.70T |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 1.33 | 6.89 |
| Enterprise to EBITDA | 10.78 | 24.14 |
| Risk & Other Metrics | ||
| Beta | 0.84 | 0.31 |
| Book Value per Share (MRQ) | ₹321.10 | ₹300.99 |
Financial Statements Comparison: Fredun vs Sun Pharmaceutical
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | FREDUN | SUNPHARMA |
|---|---|---|
| Revenue/Sales | ₹1.19B | ₹137.86B |
| Cost of Goods Sold | ₹880.59M | ₹28.15B |
| Gross Profit | ₹313.44M | ₹109.71B |
| Research & Development | ₹0 | N/A |
| Operating Income (EBIT) | ₹155.72M | ₹33.72B |
| EBITDA | ₹169.91M | ₹47.66B |
| Pre-Tax Income | ₹90.40M | ₹31.73B |
| Income Tax | ₹22.75M | ₹8.70B |
| Net Income (Profit) | ₹67.66M | ₹22.93B |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | FREDUN | SUNPHARMA |
|---|---|---|
| Cash & Equivalents | ₹6.37M | ₹102.69B |
| Total Current Assets | ₹4.28B | ₹526.24B |
| Total Current Liabilities | ₹3.21B | ₹181.94B |
| Long-Term Debt | ₹165.35M | ₹3.58B |
| Total Shareholders Equity | ₹1.41B | ₹724.86B |
| Retained Earnings | N/A | ₹578.62B |
| Property, Plant & Equipment | ₹524.89M | ₹100.36B |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | FREDUN | SUNPHARMA |
|---|---|---|
| Operating Cash Flow | N/A | N/A |
| Capital Expenditures | N/A | N/A |
| Free Cash Flow | N/A | N/A |
| Debt Repayment | N/A | N/A |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | FREDUN | SUNPHARMA |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Average Daily Volume (10 Day) | 26,613 | 2,563,431 |
| Average Daily Volume (90 Day) | 21,414 | 2,041,608 |
| Shares Outstanding | 4.72M | 2.40B |
| Float Shares | 2.71M | 1.04B |
| % Held by Insiders | 0.59% | 0.56% |
| % Held by Institutions | 0.00% | 0.25% |
Dividend Analysis & Yield Comparison: Fredun vs Sun Pharmaceutical
| Metric | FREDUN | SUNPHARMA |
|---|---|---|
| Last 12-Month Dividend | ₹0.70 | ₹21.00 |
| Last 12-Month Dividend Yield | 0.09% | 1.26% |
| 3-Year Avg Annual Dividend | ₹0.70 | ₹14.67 |
| 3-Year Avg Dividend Yield | 0.08% | 0.46% |
| 3-Year Total Dividends | ₹2.10 | ₹44.00 |
| Ex-Dividend Date | Sep 23, 2024 | Jul 07, 2025 |